TrialJournal of experimental & clinical cancer research : CR2023

Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.

Lars Henrik Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.